Drug repurposing to treat major infectious diseases
A team of researchers have combine three drug databases in the hope of repurposing drugs to treat current major infectious diseases like TB...
List view / Grid view
A team of researchers have combine three drug databases in the hope of repurposing drugs to treat current major infectious diseases like TB...
5 January 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and the California Institute for Biomedical Research (Calibr) announced they have entered into a worldwide research collaboration to develop novel small molecule anti-fibrotic therapies, and an exclusive license agreement that allows Bristol-Myers Squibb to develop, manufacture and commercialize Calibr’s preclinical compounds resulting from the collaboration...
19 March 2012 | By Merck
Calibr presents a new paradigm for academic-industry cooperation...